- Is Adamas Pharmaceuticals Inc a Buy? The Stock Rises Again
- The stock of Adamas Pharmaceuticals Inc (NASDAQ:ADMS) is a huge mover today! The stock increased 4.34% or $0.
- Why Adamas Pharmaceuticals Dropped 25.3% in February
- What: Investors in Adamas Pharmaceuticals (NASDAQ:ADMS), a small cap drug maker focused on treatments for diseases of the central nervous system, had a February to forget as the company's stock lost 25.3% of its value during the month, according to ...
- Tocqueville Asset Management L.P. Has $1133000 Position in Adamas
- Adamas Pharmaceuticals logo Tocqueville Asset Management L.P. boosted its stake in shares of Adamas Pharmaceuticals Inc (NASDAQ:ADMS) by 60.
- Adamas Reports Fourth Quarter and Full Year 2015 Financial Results
- EMERYVILLE, Calif., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc.
- Adamas Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
- EMERYVILLE, Calif., Feb. 22, 2016 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc.
Adamas is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Adamas books and related discussion.
Suggested News Resources
Great care has been taken to prepare the information on this page. Elements of the content come from factual and lexical knowledge databases, realmagick.com library and third-party sources. We appreciate your suggestions and comments on further improvements of the site.